Search

everythinglearnresearchcommunity

for

Search:↓

Human hair follicles have a unique metabolism that changes between growth stages and may contribute to baldness.

Lifestyle changes like diet and exercise are key for treating overweight women with polycystic ovary syndrome.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Finasteride affects young male rats' brain function and behavior negatively.

Finasteride affects offspring's antioxidant enzymes in epididymis, possibly disrupting sperm maturation.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Post-finasteride Syndrome causes lasting negative effects, but more research is needed for treatment and risk evaluation.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Low doses of mixed chemicals cause permanent reproductive malformations in male rats.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

iNOS contributes to hair loss in obese diabetic mice and blocking it may encourage hair growth.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Thyroid and gonadal hormones control seasonal hair growth and molting in male European badgers.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Measuring androstanediol glucuronide in blood is useful for assessing and tracking treatment in women with excessive hair growth.

Topical finasteride reduces hair loss and promotes hair growth in men and women.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

Venous catheterization may help diagnose the cause of female hyperandrogenism when imaging is unclear.